Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.

Oxford Medical Products today announces additional three-month clinical trial results for Sirona, a weight-loss treatment targeting people who are overweight or have class I obesity (BMI 25-35) and ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

Throughout his solo career and his work with NLCC, he has amassed 37 GMWA Excellence Awards, 27 Stellar Awards, three BMI Awards, two Billboard Music Awards, a Soul Train Music Award, a ...

In Thailand, the latest National Health Examination Survey (2019-2020) conducted by the Health Systems Research Institute ...

Study adds weight to calls for sugar taxes and food warning labels as obesity threatens economy and public health.

Accuray Incorporated today announced its participation in the 37th Annual Roth Conference taking place on March 16 -18, 2025 in Dana Point, ...

An agreement for Hong Kong-listed CK Hutchison Holdings (CKHH) to sell the bulk of its port interests outside of China represents a significant deal for the parties involved, with a BlackRock-led ...

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

As obesity has become a silent epidemic in India, fiscal policies must be introduced to make healthy food options affordable ...

An analysis of the FINEXT-BD data found that individuals with bipolar disorder have a 3.1% risk of cardiovascular events, ...